130 related articles for article (PubMed ID: 10461568)
21. Evaluation of 18fluoro-2-deoxyglucose positron emission tomography in iodine scan negative, differentiated thyroid cancer recurrence.
Chisholm EJ; Tolley NS
J Laryngol Otol; 2009 Oct; 123(10):1145-9. PubMed ID: 19607742
[TBL] [Abstract][Full Text] [Related]
22. Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography.
De Volder AG; Jaeken J; Van den Berghe G; Bol A; Michel C; Cogneau M; Goffinet AM
Pediatr Res; 1988 Aug; 24(2):238-42. PubMed ID: 3263613
[TBL] [Abstract][Full Text] [Related]
23. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
[TBL] [Abstract][Full Text] [Related]
24. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
[TBL] [Abstract][Full Text] [Related]
25. Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis.
Huber M; Herholz K; Pawlik G; Szelies B; Jürgens R; Heiss WD
Arch Neurol; 1989 Jan; 46(1):97-100. PubMed ID: 2783367
[TBL] [Abstract][Full Text] [Related]
26. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
Brockmann K; Reimold M; Globas C; Hauser TK; Walter U; Machulla HJ; Rolfs A; Schöls L
J Nucl Med; 2012 Jul; 53(7):1074-80. PubMed ID: 22653791
[TBL] [Abstract][Full Text] [Related]
27. Hippocampal cell density and subcortical metabolism in temporal lobe epilepsy.
Dlugos DJ; Jaggi J; O'Connor WM; Ding XS; Reivich M; O'Connor MJ; Sperling MR
Epilepsia; 1999 Apr; 40(4):408-13. PubMed ID: 10219265
[TBL] [Abstract][Full Text] [Related]
28. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
[TBL] [Abstract][Full Text] [Related]
29. Imaging in Parkinson's disease: the role of monoamines in behavior.
Brooks DJ; Piccini P
Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
[TBL] [Abstract][Full Text] [Related]
30. Wisconsin Card Sorting Test performance following head injury: dorsolateral fronto-striatal circuit activity predicts perseveration.
Lombardi WJ; Andreason PJ; Sirocco KY; Rio DE; Gross RE; Umhau JC; Hommer DW
J Clin Exp Neuropsychol; 1999 Feb; 21(1):2-16. PubMed ID: 10420997
[TBL] [Abstract][Full Text] [Related]
31. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
[TBL] [Abstract][Full Text] [Related]
32. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy.
Swartz BW; Khonsari A; Vrown C; Mandelkern M; Simpkins F; Krisdakumtorn T
Epilepsia; 1995 Apr; 36(4):388-95. PubMed ID: 7607118
[TBL] [Abstract][Full Text] [Related]
33. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
[TBL] [Abstract][Full Text] [Related]
34. Reversible striatal hypermetabolism in a case of Sydenham's chorea.
Goldman S; Amrom D; Szliwowski HB; Detemmerman D; Goldman S; Bidaut LM; Stanus E; Luxen A
Mov Disord; 1993 Jul; 8(3):355-8. PubMed ID: 8341301
[TBL] [Abstract][Full Text] [Related]
35. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.
Nurmi E; Ruottinen HM; Bergman J; Haaparanta M; Solin O; Sonninen P; Rinne JO
Mov Disord; 2001 Jul; 16(4):608-15. PubMed ID: 11481683
[TBL] [Abstract][Full Text] [Related]
36. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration.
De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM
Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014
[TBL] [Abstract][Full Text] [Related]
37. FDG-PET study of patients with Leigh syndrome.
Haginoya K; Kaneta T; Togashi N; Hino-Fukuyo N; Kobayashi T; Uematsu M; Kitamura T; Inui T; Okubo Y; Takezawa Y; Anzai M; Endo W; Miyake N; Saitsu H; Matsumoto N; Kure S
J Neurol Sci; 2016 Mar; 362():309-13. PubMed ID: 26944169
[TBL] [Abstract][Full Text] [Related]
38. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
[TBL] [Abstract][Full Text] [Related]
39. Fluorodeoxyglucose F18 positron emission tomography in a case of slowly progressive pure alexia.
Graff-Radford J; Benarroch EE; Duffy JR; Drubach DA
Neurocase; 2014 Aug; 20(4):476-9. PubMed ID: 23998338
[TBL] [Abstract][Full Text] [Related]
40. Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease.
al-Essa MA; Rashed MS; Bakheet SM; Patay ZJ; Ozand PT
J Perinatol; 2000 Mar; 20(2):120-8. PubMed ID: 10785889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
